TYRA-300 0.125 mg/kg
TYR300-201
Phase 2 small_molecule active
Quick answer
TYRA-300 0.125 mg/kg for Achondroplasia is a Phase 2 program (small_molecule) at Tyra Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tyra Biosciences
- Indication
- Achondroplasia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active